BeOne Medicines AG
public_traded
BeOne Medicines AG is publicly traded on HKSE under ticker 6160.HK.
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.